Health & Fitness
Health and Fitness
Health and Fitness
Fri, June 17, 2011
Thu, June 16, 2011 Obagi Reports on the Skincare Challenges Facing Women with Skin of Color
LONG BEACH, Calif.--([ BUSINESS WIRE ])--One skincare regimen does not fit all, and this fact is especially apparent in the results of a new poll sponsored by Obagi Medical Products (Nasdaq: OMPI) that surveyed more than 1,000 women within the wide range of askin of color.a The results indicated that whether a woman is of African-American, Hispanic, Asian or Middle Eastern descent, one thing holds true: she most likely has unresolved skin challenges.
"The results indicate to us that we have an opportunity and obligation to educate women about the treatments that are available for many of the skin conditions noted; and that partnering with a physician is critical in achieving desired results."
A prominent concern among women with skin of color is related to pigment. Obagi found that:
- 47% see a dermatologist for dark spots, uneven skin tone or hyperpigmentation
However, only 11% of the surveyed women expressed a strong familiarity with an ingredient considered by many dermatologists to be the gold standard in treating certain pigmentary disorders a" hydroquinone. In fact:
- 61% of the women were not at all familiar with the ingredient
58% of surveyed women say they struggle to find skincare products that meet their needs, suggesting an opportunity to further educate consumers about available treatments. Even when they have found products they are willing to purchase:
- less than half of those polled (47%) said their current regimen meets their expectations, despitea
- most of the women (52%) spending more than $100 on skincare products in the last year.
Obagi also uncovered a lack of concern over one of the most common causes of discoloration: sun exposure.
- Most of the women surveyed claim to wear a sunscreen with an SPF rating of at least 15 every day; howevera
- 16% of those who dona™t wear sunscreen believe ita™s not important for skin of color.
aObagi Medical commissioned this poll to help us better understand the needs and concerns of our consumers,a Jim Hartman, Vice President, Global Marketing and Business Development said. aThe results indicate to us that we have an opportunity and obligation to educate women about the treatments that are available for many of the skin conditions noted; and that partnering with a physician is critical in achieving desired results.a
Regardless of ethnicity, this poll suggests that partnering with a knowledgeable professional can be beneficial when managing the skincare challenges faced by women with skin of color.
About Obagi Medical Products, Inc.
Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, and is a leading provider of, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeuticsa" technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles. Obagi Medicala™s portfolio, which includes cosmetic, over-the-counter and prescription products, including 4% hydroquinone, is sold and promoted only through physician offices and requires education by a physician on proper use. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly stable vitamin C serums), Obagi Condition &Enhance® for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm® Eye Treatment and Obagi CLENZIderm® M.D. acne therapeutic systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to dry skin, and Obagi ELASTIderm D©colletage System, Obagi Rosaclear® System, Obagi ELASTILasha" Eyelash Solution, Obagi Blue Peel RADIANCETM, and Nu-Derm® Sun Shield SPF 50. Visit [ www.obagi.com ] for information.
Blue Peel RADIANCE, ELASTIlash and Penetrating Therapeutics are trademarks, and Obagi, Blue Peel, Condition & Enhance, ELASTIderm, Nu-Derm, Obagi-C, Obagi CLENZIderm and Rosaclear are registered trademarks, of Obagi Medical Products, Inc. and/or its affiliates in the United States and certain other countries.
